Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study

RecruitingOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

December 20, 2027

Study Completion Date

December 31, 2027

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
DIAGNOSTIC_TEST

Urine proteomics

Patients with hepatocellular carcinoma amenable to radical resection were included according to the inclusion exclusion criteria, and preoperative urine and postoperative urine from consecutive patients were collected at the marker time (before receiving postoperative adjuvant therapy after radical surgery for hepatocellular carcinoma) and at the longitudinal time (at the time point of 3 months after radical surgery), and the different samples were preprocessed, followed by mass spectrometry-based urinary proteomics to detect the differences in urinary proteins, and the data were recorded to compare the differences.

Trial Locations (1)

Unknown

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER